Published in
Taylor and Francis Group, Expert Opinion on Biological Therapy, 5(11), p. 551-557, 2011
DOI: 10.1517/14712598.2011.567262
Links
Tools
The clinical and biological role of CD20 membrane antigen modulation under immunotherapy with anti-CD20 monoclonal antibody rituximab in lymphoprolipherative neoplastic disorders
Journal article published in 2011 by
Pellegrino Musto,
Fiorella D'Auria 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 